These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

135 related articles for article (PubMed ID: 417373)

  • 61. Central dopamine and noradrenaline receptor activity of the amines formed from m-tyrosine, alpha-methyl-m-tyrosine and alpha-methyldopa.
    Andén NE; Butcher SG; Engel J
    J Pharm Pharmacol; 1970 Jul; 22(7):548-50. PubMed ID: 4395068
    [No Abstract]   [Full Text] [Related]  

  • 62. Effect of des-Tyr1-gamma-endorphin and des-Tyr1-alpha-endorphin on alpha-MPT-induced catecholamine disappearance in rat brain nuclei: a dose--response study.
    Versteeg DH; Kovács GL; Bohus B; de Kloet ER; de Wied D
    Brain Res; 1982 Jan; 231(2):343-51. PubMed ID: 6120024
    [TBL] [Abstract][Full Text] [Related]  

  • 63. Modulation in the sensitivity of noradrenergic receptors in the CNS studied by the responsiveness of the cyclic AMP system.
    Baudry M; Martres MP; Schwartz JC
    Brain Res; 1976 Oct; 116(1):111-24. PubMed ID: 184881
    [TBL] [Abstract][Full Text] [Related]  

  • 64. Different alpha-adrenoreceptors in the central nervous system mediating biochemical and functional effects of clonidine and receptor blocking agents.
    Andén NE; Grabowska M; Strömbom U
    Naunyn Schmiedebergs Arch Pharmacol; 1976; 292(1):43-52. PubMed ID: 6918
    [TBL] [Abstract][Full Text] [Related]  

  • 65. Differential effects of D- and L-amphetamine on behavior and on catecholamine disposition in dopamine and norepinephrine containing neurons of rat brain.
    Taylor KM; Snyder SH
    Brain Res; 1971 May; 28(2):295-309. PubMed ID: 5113521
    [No Abstract]   [Full Text] [Related]  

  • 66. Lithium inhibition of norepinephrine and dopamine receptors.
    Flemenbaum A
    Biol Psychiatry; 1977 Aug; 12(4):563-72. PubMed ID: 560884
    [TBL] [Abstract][Full Text] [Related]  

  • 67. Implications for multiple transmitter mediation of amphetamine-induced stereotypies.
    Cheal M; Kurkulos ME; Silva L
    Pharmacol Biochem Behav; 1982 Dec; 17(6):1305-8. PubMed ID: 6891794
    [TBL] [Abstract][Full Text] [Related]  

  • 68. The effect of noradrenergic receptor blocking agents on 5-hydroxytryptamine turnover in the brain of rats.
    Zebrowska-Lupina I
    Pol J Pharmacol Pharm; 1976; 28(4):341-7. PubMed ID: 135973
    [TBL] [Abstract][Full Text] [Related]  

  • 69. Cerebral dopamine and noradrenaline turnover and effects of morphine test dose in rats withdrawn from 20 days' morphine treatment.
    Attila LM; Ahtee L
    Med Biol; 1983; 61(5):249-257. PubMed ID: 6686987
    [TBL] [Abstract][Full Text] [Related]  

  • 70. Dopaminergic substrates of amphetamine-induced place preference conditioning.
    Spyraki C; Fibiger HC; Phillips AG
    Brain Res; 1982 Dec; 253(1-2):185-93. PubMed ID: 6817850
    [TBL] [Abstract][Full Text] [Related]  

  • 71. FLA 136: selective agonist at central alpha-adrenoreceptors mediating changes in the turnover of noradrenaline.
    Andén NE; Grabowska M
    Naunyn Schmiedebergs Arch Pharmacol; 1977 Jul; 298(3):239-43. PubMed ID: 19710
    [No Abstract]   [Full Text] [Related]  

  • 72. Effects of prostaglandins on catecholamine metabolism of the central nervous system in rats.
    Telegdy G
    Acta Physiol Acad Sci Hung; 1981; 57(3):221-4. PubMed ID: 6946681
    [TBL] [Abstract][Full Text] [Related]  

  • 73. An intact dopaminergic system is required for context-conditioned release of 5-HT in the nucleus accumbens of postweaning isolation-reared rats.
    Fulford AJ; Marsden CA
    Neuroscience; 2007 Oct; 149(2):392-400. PubMed ID: 17869434
    [TBL] [Abstract][Full Text] [Related]  

  • 74. Catecholamine turnover in rat cerebral cortex and caudate following repeated treatment with dihydroergotoxine.
    Cvejić V; Mrsulja BB
    Gerontology; 1981; 27(1-2):7-12. PubMed ID: 6111518
    [TBL] [Abstract][Full Text] [Related]  

  • 75. Role of vesicular dopamine in the in vivo stimulation of striatal dopamine transmission by amphetamine: evidence from microdialysis and Fos immunohistochemistry.
    Cadoni C; Pinna A; Russi G; Consolo S; Di Chiara G
    Neuroscience; 1995 Apr; 65(4):1027-39. PubMed ID: 7617159
    [TBL] [Abstract][Full Text] [Related]  

  • 76. Comparison of 2, 5-dimethoxy-4-methylamphetamine (DOM) and d-amphetamine for in vivo efflux of catecholamines from rat brain.
    Vrbanac JJ; Tilson HA; Moore KE; Rech RH
    Pharmacol Biochem Behav; 1975; 3(1):57-64. PubMed ID: 1129355
    [TBL] [Abstract][Full Text] [Related]  

  • 77. A new and highly sensitive method for measuring 3-methoxytyramine using HPLC with electrochemical detection. Studies with drugs which alter dopamine metabolism in the brain.
    Heal DJ; Frankland AT; Buckett WR
    Neuropharmacology; 1990 Dec; 29(12):1141-50. PubMed ID: 2293058
    [TBL] [Abstract][Full Text] [Related]  

  • 78. Circling behavior following systemic d-amphetamine administration: potential noradrenergic and dopaminergic involvement.
    Kokkinidis L; Anisman H
    Psychopharmacology (Berl); 1979 Jun; 64(1):45-54. PubMed ID: 113831
    [TBL] [Abstract][Full Text] [Related]  

  • 79. Dopamine receptors and ergot drugs. Evidence that an ergolene derivative is a differential agonist at subcortical limbic dopamine receptors.
    Fuxe K; Fredholm BB; Agnati LF; Corrodi H
    Brain Res; 1978 May; 146(2):295-311. PubMed ID: 647392
    [TBL] [Abstract][Full Text] [Related]  

  • 80. Effect of nomifensine on motor activity, dopamine turnover rate and cyclic 3',5;-adenosine monophosphate concentrations of rat striatum.
    Gerhards HJ; Carenzi A; Costa E
    Naunyn Schmiedebergs Arch Pharmacol; 1974; 286(1):49-63. PubMed ID: 4375258
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.